Moderna’s Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn monthlywealthstream
On Thursday, Moderna Inc. (NASDAQ:MRNA) reported third-quarter revenue of $1.83 billion, beating the consensus of $1.25 billion. The company attributed the growth to higher sales in the U.S. market following the earlier launch of the updated COVID-19 vaccine. BofA Securities notes that Moderna’s stock rose early Thursday but ended the day lower, likely due to slowing vaccine […]